Progyny, Inc. ROE

ROE of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROE growth rates and interactive chart. ROE is expressed as a percentage and can be calculated for any company if net income and equity are both positive numbers. Net income is calculated before dividends paid to common shareholders and after dividends to preferred shareholders and interest to lenders. A company with average equity of $10 million and earnings of $2 milion will have a ROE of 20%.


Highlights and Quick Summary

  • Annual ROE for 2020 was 33.04% (a -136.93% decrease from previous year)
  • Annual ROE for 2019 was -89.47% (a -1656.0% decrease from previous year)
  • Annual ROE for 2018 was 5.75% (a Infinity% increase from previous year)
  • Twelve month ROE ending June 29, 2021 was 48.33% (a 27.86% increase compared to previous quarter)
  • Twelve month trailing ROE increased by 65.4% year-over-year
Trailing ROE for the last four month:
29 Jun '21 30 Mar '21 30 Dec '20 29 Sep '20
48.33% 37.8% 32.89% 29.22%
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROE of Progyny, Inc.

Most recent ROEof PGNY including historical data for past 10 years.

Interactive Chart of ROE of Progyny, Inc.

Progyny, Inc. ROE for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 33.04%
2019 -89.47%
2018 5.75%
2017 0.0%

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.